English
Contact Sales
QIAGEN Webshop
Resellers
MyCLC
Search
Search
Solutions
Discovery and Research
Biomarker and Target Discovery
Single-Cell Genomics
Microbial/Metagenomics
Gene Regulation
Variant Analysis
SARS-CoV-2 Solutions
OmicSoft NGS Data Analysis
–
Explore and compare data across 700K+ disease studies with a cloud-based NGS analysis suite
Data Sciences
Data and Pipeline Management
OmicSoft OncoLand
–
Explore high-quality, preprocessed genomics data with our oncology database
Webinar: Jun. 13 – How decentralized and small labs can adopt high-throughput NGS analysis
–
Discover a new secondary analysis solution for oncology & inherited disease applications for high-throughput use with any clinical NGS data
Clinical NGS Testing
Oncology
Solid Tumors
Hematological Malignancies
Hereditary Cancers
Inherited Disorders
Rare & Undiagnosed Diseases
Carrier Screening
Cardiac Disorders
Arrhythmias
Cardiomyopathies
Sample to Insight solutions
–
View our NGS workflows for labs of all sizes and experience – and find the right fit for you
Partner Program
Rare and Undiagnosed Diseases
–
Finding a diagnosis for rare diseases is often a race against time. QDI is helping provide answers where none were available before.
Biomarker and Target Discovery
–
Augment your biomarker discovery research with 20M findings & 700K preprocessed `omics samples
Clinical Testing Solutions
–
Deliver patient-specific reports for any NGS panel in minutes with on-demand, expert-curated content & professional interpretation services
Products
Applications
Secondary Analysis Tools
QIAGEN CLC Workbench Premium
QIAGEN CLC Main Workbench
QIAGEN CLC Module and Plugin Overview
QIAGEN CLC Genome Finishing Module
QIAGEN CLC Microbial Genomics Module
QIAGEN CLC Genomics
QIAGEN CLC Genomics Workbench
Clinical Insights
NGS Secondary Analysis
QCI Secondary Analysis (Cloud-Based)
Clinical Interpretation & Reporting
QCI Interpret for Hereditary Diseases
QCI Interpret for Oncology
QCI Precision Insights
Gene Variant Databases
COSMIC (Catalogue of Somatic Mutations in Cancer)
HSMD (Human Somatic Mutation Database)
HGMD (Human Gene Mutation Database)
Interpretation and Visualization
QIAGEN OmicSoft
QIAGEN OmicSoft Suite
Enterprise NGS Solutions
QIAGEN CLC Genomics Server
QIAGEN CLC Server Command Line Tools
QIAGEN CLC Genomics Cloud Engine
QIAGEN OmicSoft Suite
Sample to Insight Solutions
QCI Interpret for Oncology
–
The most advanced end-to-end solution for oncology NGS analysis, interpretation and reporting
Ingenuity Pathway Analysis (IPA)
–
Analyze, compare and contextualize your NGS data with the leading pathway analysis application
Knowledge Bases
QIAGEN Biomedical Knowledge Base
Gene Variant Databases
COSMIC (Catalogue of Somatic Mutations in Cancer)
HSMD (Human Somatic Mutation Database)
HGMD (Human Gene Mutation Database)
‘Omics Database
QIAGEN Biomedical Knowledge Base
QIAGEN DiseaseLand
QIAGEN GeneticsLand
QIAGEN OncoLand
QIAGEN Single Сell Land
ATCC Cell Line Land
QIAGEN OmicSoft Land Explorer
Biomedical Knowledge Base-AI
–
Find novel connections missed by traditional methods, hiding in over 640M biomedical relationships
Services
QIAGEN Discovery Bioinformatics Services
Clinical Analysis and Interpretation Services
Biomedical Knowledge Bases
–
Access critical drug discovery data, save time and explore novel biomedical relationships
QCI Precision Insights
–
A professional clinical interpretation service that translates molecular data specific to each patient into insights and therapeutic options
Biomedical Knowledge Base-HD
–
Directly access over 10M high-quality biological findings
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret
–
QCI Interpret is the first NGS interpretation platform to be certified under IVDR for both oncology and hereditary applications
Which secondary analysis solution is right for you?
–
Use our decision tree to find out which secondary analysis solution is right for your lab
Resources
News
Press Releases
Blog
QIAGEN Clinical Insight Interpret receives European IVDR certification
–
QCI Interpret is the first NGS interpretation platform to be certified under IVDR for both oncology and hereditary applications.
Latest Blog: The use of NGS in food and feed safety
–
See how experts leverage CLC Genomics Workbench Premium for food and animal feed testing
Science
Case Studies
Technical Information
Public Citations
Citation Guidelines
Allele Frequency Community
SARS-CoV-2 Resources
Knowledge Bases Blog: Using trusted cancer data can accelerate drug discovery and development
–
See our expert curation processes and how data curated this way helps biopharma research
Latest IPA Blog: Free pathway analysis – How much do you really save?
–
Discover why you need pathway analysis tools that provide rich, directional relationships
Webinars and Events
Webinar: Jun. 6 – Investigating genomic variants using QDI Software
–
Learn to analyze various types of NGS data with CLC Genomics Workbench, QCII Translational and IPA
Latest Blog: Immune Repertoire Analysis Showdown: Speed, Ease, Accuracy
–
Find out which B-cell receptor reconstruction tool takes the crown
Webinar: Jun. 6 – Investigating genomic variants with QDI Software
–
Learn to analyze various types of NGS data with CLC Genomics Workbench, QCII Translational and IPA
Blog: How COSMIC & HSMD support different phases of cancer drug discovery and development
–
Learn how expert-curated cancer data can help biopharma researchers identify & validate drug targets faster & optimize clinical trial design
Support
Technical Support
QIAGEN CLC Tutorials
Contact Support
FAQs
Product Manuals
Latest Improvements
Maintenance and Support
Latest improvements: IPA
–
See the newest improvements and updates in the IPA 2024R1 Release
Video: Introduction to QCI Interpret for Oncology
–
Check out this introductory video to QCI Interpret for Oncology, a CDS software that will allow you to confidently interpret NGS variants
Training
IPA Training
Upcoming Webinars
Webinar Recordings
Technical Information
Webinar: Jun. 18 – Leveraging the QIAGEN Knowledge Graph for insights into drug repurposing
–
This webinar shows how to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence.
Webinar: Jun. 18 – HGMD Pro in action: Search, curate and classify genetic variants – Session 2
–
Learn how HGMD Professional can help you get better variant data faster
Downloads
Product Downloads
Module and Plugin Downloads
Example Data
3d Graphics Support
Somatic knowledge bases for clinical NGS testing
–
Expert-curated content for accelerated analysis of cancer mutations in clinical NGS testing
System Requirements
Latest news from QIAGEN Digital Insights
–
See our most recent announcements and press releases
Press Release: QIAGEN launches AI-derived biomedical knowledge base to accelerate drug discovery
–
Welcoming QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base for drug discovery
Licensing
License transfer
MyCLC
Somatic knowledge bases for biopharmaceutical research
–
Expert-curated content for the discovery and development of precision cancer therapies
Human Gene Mutation Database (HGMD) Professional
–
Improve diagnostics with the largest expert-curated source of hereditary disease-causing mutations
Latest improvements: OmicSoft Lands
–
See the latest improvements and updates in the Lands 2024R1 Release
Press Release: QIAGEN enhances bioinformatics workflows with new secondary analysis solution
–
QIAGEN launches QCI Secondary Analysis, a cloud-based solution enabling high-throughput secondary analysis with any clinical NGS data.
Video: Introduction to QCI for Hereditary Disorders
–
Check out this introductory video to QCI Interpret for Hereditary Disorders, industry’s only automated FASTQ to final report solution
About
QIAGEN Digital Insights
About Us
Contact
Careers
QIAGEN Corporate
Request a Trial
Product Login
Contact
Shop
How to Purchase
Contact Sales
QIAGEN Webshop
Resellers
MyCLC
Search
Search
QCI Interpret Translational
ANNOVAR
Are you using the right tools for you data interpretation and reporting needs?
Click on the application you are interested in learning more about
Inherited and rare disease
Hereditary Cancer
Somatic CANCER
Translational Research
